TECH vs UHS — Key Metrics
| Metric | TECH (BIO-TECHNE CORP) | UHS (UNIVERSAL HEALTH SERVICES INC) |
|---|---|---|
| Price | 72.75 | 186.07 |
| Market Cap | 11.43 Billion | 10.73 Billion |
| P/E (TTM) | 66.14 | 7.71 |
| P/B (Quarterly) | 5.284 | 1.484 |
| P/S (TTM) | 9.3 | 0.58 |
| Net Profit Margin (TTM) | 14.0 | 8.0 |
| Gross Margin (TTM) | 65.8 | 43.7 |
| ROE (TTM) | 8.2 | 19.6 |
| Revenue Growth YoY (TTM) | n/a | n/a |
Upfront Investment - S&P 500 Stock Comparison & AI Analysis
AI-powered analysis and comparison tools for S&P 500 stocks, helping investors make data-driven decisions with delayed market data and portfolio modeling.
Performance Comparison
AI Model Recommendation
Underperform
Outperform
Recommendation Summary
Stock TECH is projected to underperform the market, stock UHS is projected to outperform the market. Upfront Recommendation: UHS.
Financial Metrics
| TECH | Metrics | UHS |
|---|---|---|
| $72.75 | Price | $186.07 |
| — | Market Capitalization | — |
| 66.14 | Price to Earnings Ratio | 7.71 |
| 9.3 | Price to Sales | 0.58 |
| 37.08 | Price to FCF Ratio | 9.81 |
| 14.15 | Price to Gross Profit | 1.34 |
| 13.86 | Price to Current Assets | 2.91 |
TECH vs UHS at a glance
Bio-techne Corp (TECH) and Universal Health Services INC (UHS) are both in the Healthcare sector. They are similar in size: $11.4 billion and $10.7 billion in market value.
On trailing-twelve-month figures, TECH trades at 66.1 times trailing earnings and UHS at 7.7; net profit margins are 14.0% and 8.0%.
The Upfront Investment model currently rates TECH Underperform and UHS Outperform as of November 18, 2026. The rating ranks the model's medium-term return forecast against the other stocks it scores; it is a statistical forecast, not investment advice.